PeptidePedia The community reference

Trial data comparison: difference between revisions

Diff·revision 3 → 4·19:24, 17 Dec 2024

Difference between revision 3 and revision 4 of Trial data comparison. 3 lines changed; the page grew by 177 bytes.

Revision 3 — 20:54, 15 Dec 2024
NPOV_Nadia (talk)
copyedit
1,337 bytes ±0
Revision 4 — 19:24, 17 Dec 2024
ChromCleanupCass (talk)
rv unexplained removal of sourced content
1,514 bytes +177
9The table is easy to misread in one specific way, and the article exists partly to prevent it. '''Two figures from two trials are not a comparison of two drugs.''' Trial populations differ in baseline weight, glycaemic status, diabetes duration, background therapy and geography; durations differ; and the statistical estimand used to summarise a weight-change endpoint differs between publications and sometimes within a single one.{{r|ich9r1}} A larger number in this table means a larger result in that trial, and nothing more.9The table is easy to misread in one specific way, and the article exists partly to prevent it. '''Two figures from two trials are not a comparison of two drugs.''' Trial populations differ in baseline weight, glycaemic status, diabetes duration, background therapy and geography; durations differ; and the statistical estimand used to summarise a weight-change endpoint differs between publications and sometimes within a single one.{{r|ich9r1}} A larger number in this table means a larger result in that trial, and nothing more.
1010
+11== The comparison ==
+12Filter by compound, trial programme or endpoint type. The bar is drawn to the magnitude of the primary result and is scaled within its endpoint type only.
+13
11== References ==14== References ==
12{{reflist}}15{{reflist}}